[Form 4/A] Waystar Holding Corp. Amended Insider Trading Activity
Rhea-AI Filing Summary
Waystar Holding Corp. (WAY) amended Form 4 reporting activity by Melissa F. Miller, Chief Marketing Officer. The amendment adds an option exercise of 3,400 shares at an exercise price of $18.19 on 05/15/2025 and restates a contemporaneous sale of 3,400 shares at a weighted-average price of $39.1863. The filing shows beneficial ownership moved from 205,356 shares immediately after the exercise to 201,956 after the sale. The transactions were executed automatically under a 10b5-1 plan adopted 11/20/2024, and the amendment corrects an earlier omission of the exercise from the original Form 4.
Positive
- Amendment corrects prior omission and consolidates transactions for clearer disclosure
- Transactions executed pursuant to a 10b5-1 plan (adopted 11/20/2024), indicating preplanned sales
- Filing discloses option exercise details including exercise price ($18.19) and vesting description
Negative
- Reporting person sold 3,400 shares at a weighted-average price of $39.1863, reducing beneficial ownership
- Initial Form 4 omitted the option exercise, requiring this corrective amendment
Insights
TL;DR: Routine option exercise and share sale reported; amendment fixes a prior omission, limited market impact.
The amendment discloses a contemporaneous option exercise and sale of 3,400 shares by an officer, with proceeds realized at a weighted-average sale price of $39.1863 versus an $18.19 exercise price, implying a material per-share gain on the exercised options. Because the trades were executed under a pre-existing 10b5-1 plan and the filing corrects an administrative omission, this is a routine insider liquidity event rather than a company operational development. The net change in beneficial ownership (from 205,356 to 201,956 shares) is small relative to typical public-company float levels and unlikely to be material to valuation on its own.
TL;DR: Amendment improves disclosure compliance; use of a documented 10b5-1 plan reduces insider-trading concerns.
The filing clarifies prior reporting by adding an omitted option exercise and consolidating related entries. The clear statement that the transactions occurred pursuant to a 10b5-1(c) plan adopted on 11/20/2024 and the attorney-in-fact signature enhance procedural transparency. Inclusion of unvested RSUs and vesting terms for the option grant are explicitly noted, which supports clearer ownership tracking. This corrected disclosure aligns with best practices for timely and complete insider reporting.